Brainstorm Cell Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 52,501 | $119,206 | 100.00% | 0.99% |
BLACKROCK, INC. | 02/07/2025 | 25,172 | $57,140 | 100.00% | 0.47% |
LIBERTY WEALTH MANAGEMENT LLC | 02/10/2025 | 22,666 | $51,452 | -93.34% | 0.43% |
HRT FINANCIAL LP | 02/14/2025 | 20,022 | $45,000 | 100.00% | 0.38% |
WEAVER CONSULTING GROUP | 01/08/2025 | 15,623 | $35,464 | -93.33% | 0.29% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 11,300 | $25,651 | 100.00% | 0.21% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 10,519 | $2,419 | 0.00% | 0.20% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 6,016 | $13,657 | 100.00% | 0.11% |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 747 | $1,695 | -93.35% | 0.01% |
ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 334 | $758 | 100.00% | 0.01% |
02/06/2025 | 167 | $379 | 100.00% | 0.00% | |
02/13/2025 | 148 | $336 | 100.00% | 0.00% | |
EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 141 | $320 | 100.00% | 0.00% |
02/11/2025 | 120 | $272 | 100.00% | 0.00% | |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 113 | $257 | 100.00% | 0.00% |
CLEARSTEAD ADVISORS, LLC | 02/10/2025 | 100 | $227 | 100.00% | 0.00% |
CRANBROOK WEALTH MANAGEMENT, LLC | 01/15/2025 | 66 | $150 | 100.00% | 0.00% |
ST GERMAIN D J CO INC | 01/10/2025 | 33 | $75 | -93.40% | 0.00% |
02/03/2025 | 20 | $45 | 100.00% | 0.00% | |
CBIZ INVESTMENT ADVISORY SERVICES, LLC | 02/10/2025 | 13 | $30 | 100.00% | 0.00% |
WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/17/2025 | 12 | $28 | 100.00% | 0.00% |
CORECAP ADVISORS, LLC | 02/14/2025 | 8 | $18 | 100.00% | 0.00% |
BOGART WEALTH, LLC | 01/30/2025 | 2 | $5 | -94.12% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHERN TRUST CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
CLEARSTEAD ADVISORS, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
JANNEY MONTGOMERY SCOTT LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
BANGOR SAVINGS BANK | 01/07/2025 | 0 | $0 | -100.00% | 0.00% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
CREATIVE PLANNING | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SAXONY CAPITAL MANAGEMENT, LLC | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
JUMP FINANCIAL, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 01/22/2025 | 0 | $0 | -100.00% | 0.00% |
Brainstorm Cell Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of Brainstorm Cell Therapeutics Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 52,501
BlackRock, Inc.: 25,172
LIBERTY WEALTH MANAGEMENT LLC: 22,666
HRT FINANCIAL LP: 20,022
Weaver Consulting Group: 15,623
TWO SIGMA SECURITIES, LLC: 11,300
4.81% of Brainstorm Cell Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 838,936 shares in the last 24 months. This purchase volume represents approximately $637,591 in transactions.